These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 16149638

  • 41. Urinary bile acids: a noninvasive measure of liver function and bile acid metabolism?
    Suchy FJ.
    J Pediatr Gastroenterol Nutr; 1984 Nov; 3(5):649-51. PubMed ID: 6502366
    [No Abstract] [Full Text] [Related]

  • 42. [Role of carcinoembryonic antigen, carbohydrate antigen 19-9 and cytology of bile in diagnosis of biliary and pancreatic cancer].
    Matsuda M, Shimizu Y, Chikamatsu E, Takayanagi K, Ishigure H, Murakami S, Odani K.
    Nihon Geka Gakkai Zasshi; 1991 Jun; 92(6):716-21. PubMed ID: 1886576
    [Abstract] [Full Text] [Related]

  • 43. A measurement of individual bile acids in serum by high-performance liquid chromatography for clinical diagnostic information of hepatobiliary diseases.
    Baba S, Uenoyama R, Suminoe K, Takeda F, Hasegawa S, Kameno Y.
    Kobe J Med Sci; 1980 Jun; 26(2):89-99. PubMed ID: 7401589
    [No Abstract] [Full Text] [Related]

  • 44. [Complex endoscopic diagnosis of cancer of the hepato-pancreato-duodenal region].
    Balalykin AS, Khalilov SI, Avaliani MV, Shukshina IV.
    Klin Med (Mosk); 1984 Aug; 62(8):63-7. PubMed ID: 6492721
    [No Abstract] [Full Text] [Related]

  • 45. [Ultrasonically guided percutaneous fine needle biopsy in the diagnosis of tumors of the liver, pancreas and biliary system].
    Dong BW.
    Zhonghua Yi Xue Za Zhi; 1984 Jun; 64(6):348-50. PubMed ID: 6437633
    [No Abstract] [Full Text] [Related]

  • 46. [Lysophospholipids].
    Nakamura K, Yatomi Y.
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():809-11. PubMed ID: 16149647
    [No Abstract] [Full Text] [Related]

  • 47. Biochemical assay of serum bile acids: methods and applications.
    Azer SA, Klaassen CD, Stacey NH.
    Br J Biomed Sci; 1997 Jun; 54(2):118-32. PubMed ID: 9231460
    [Abstract] [Full Text] [Related]

  • 48. [Cholyl glycine (CG)].
    Yoneda M, Shimada T, Hiraishi H.
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():806-8. PubMed ID: 16149646
    [No Abstract] [Full Text] [Related]

  • 49. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
    Nakao A, Taniguchi K, Inoue S, Takeda S, Harada A, Nonami T, Watanabe K, Takagi H.
    Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
    [Abstract] [Full Text] [Related]

  • 50. [Comparative evaluation of the diagnostic importance of determining 5-nucleotidase and alkaline phosphatase in the blood serum in liver and biliary tract diseases].
    Terletskaia LM.
    Vestn Khir Im I I Grek; 1981 Oct; 127(10):47-51. PubMed ID: 6274079
    [Abstract] [Full Text] [Related]

  • 51. High performance liquid chromatographic determination of individual bile acids in serum for automatic diagnosis of various liver and biliary diseases.
    Zhao RH, Li BY, Chen N, Zhang YK, Wang ZY, Lu PC.
    Biomed Chromatogr; 1993 Oct; 7(3):139-42. PubMed ID: 8318830
    [Abstract] [Full Text] [Related]

  • 52. [Tumor markers in the diagnosis of tumors of the liver and biliary tract].
    Marecek Z.
    Vnitr Lek; 1997 Mar; 43(3):167-70. PubMed ID: 9221578
    [Abstract] [Full Text] [Related]

  • 53. [Use of the thermovision method study of diseases of the pancreas, liver and biliary tract].
    Miroshnikov MM, Mel'nikova VP, Sukharev VF, Cherniaev IuS, Kozlov OA.
    Vestn Khir Im I I Grek; 1974 Apr; 112(4):15-20. PubMed ID: 4454136
    [No Abstract] [Full Text] [Related]

  • 54. Clinical study of urinary sulfated bile acids in patients with hepatitis C virus.
    Tetsutani T, Adachi K, Suzuki T, Kiyohara S.
    Hepatogastroenterology; 2010 Apr; 57(104):1483-8. PubMed ID: 21443107
    [Abstract] [Full Text] [Related]

  • 55. [Clinical significance of CA 50 assay as a tumor marker].
    Hara K, Mitsuhashi F, Ohkura H.
    Nihon Rinsho; 1990 Feb; 48 Suppl():971-3. PubMed ID: 2192182
    [No Abstract] [Full Text] [Related]

  • 56. P53 levels in the evaluation of malignant/benign pancreaticobiliary disease: hope or hype?
    Gessner CE, Baillie J.
    Am J Gastroenterol; 1996 Feb; 91(2):401-2. PubMed ID: 8607524
    [No Abstract] [Full Text] [Related]

  • 57. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
    Kim HJ, Kim MH, Myung SJ, Lim BC, Park ET, Yoo KS, Seo DW, Lee SK, Min YI.
    Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
    [Abstract] [Full Text] [Related]

  • 58. Serum and urinary fucose concentrations in hepatitis B-related cirrhosis and acute liver diseases.
    Sathish Kumar N, Eapen CE, Jeyamani R, Balasubramanian KA.
    Clin Chim Acta; 2004 Apr; 342(1-2):233-5. PubMed ID: 15026286
    [No Abstract] [Full Text] [Related]

  • 59. [Liver, pancreas, biliary tract cancer].
    Miyazaki M.
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1207. PubMed ID: 25528773
    [No Abstract] [Full Text] [Related]

  • 60. [Isoferritin].
    Yamaguchi K.
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():736-40. PubMed ID: 16149627
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.